Radiation InjuriesAntineoplastic AgentsRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationNeoplasmsRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationCombined Modality TherapyRadiation OncologyRadiation ProtectionCell Line, TumorRadiotherapy, ConformalDrug Screening Assays, AntitumorRadiation MonitoringRadiotherapy, Intensity-ModulatedDrug Resistance, NeoplasmDose FractionationRadiotherapy, AdjuvantRadiotherapy Planning, Computer-AssistedRadiation PneumonitisBreast NeoplasmsProstatic NeoplasmsNeoplasms, Radiation-InducedBrachytherapyApoptosisCisplatinRadiation-Sensitizing AgentsRadiometryCell SurvivalDoxorubicinDrug Delivery SystemsRadiation Injuries, ExperimentalMice, NudeDrug DesignDrug DiscoveryRadiosurgeryGamma RaysTreatment OutcomeNeoplasm Recurrence, LocalMolecular Targeted TherapyCosmic RadiationXenograft Model Antitumor AssaysBrain NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHead and Neck NeoplasmsCell ProliferationLung NeoplasmsRadiotherapy, Computer-AssistedNeoplasm StagingClinical Trials as TopicGene Expression Regulation, NeoplasticCarcinoma, Squamous CellCranial IrradiationTime FactorsRetrospective StudiesTumor Cells, CulturedSurvival AnalysisRadiotherapy, Image-GuidedParticle AcceleratorsAntineoplastic Agents, PhytogenicSurvival RateRadiation-Protective AgentsRadiodermatitisBackground RadiationDNA DamageFollow-Up StudiesDisease-Free SurvivalDrug Resistance, MultipleRadiotherapy, High-EnergyFluorouracilAdenocarcinomaDrug CarriersDose-Response Relationship, DrugInhibitory Concentration 50PrognosisUltraviolet RaysDrug ApprovalMedical OncologyOrgans at RiskTumor BurdenCell CycleDrugs, InvestigationalNeoplasm ProteinsChemotherapy, AdjuvantMolecular StructureNeoplasm MetastasisColonic NeoplasmsChemoradiotherapyEarly Detection of CancerCobalt RadioisotopesPaclitaxelCarcinoma, Non-Small-Cell LungTomography, X-Ray ComputedAntibiotics, AntineoplasticRadiation EffectsPancreatic NeoplasmsUnited States